Cancer Vaccine Trials—Using Same mRNA Tech Behind Covid Shots—Could Launch In U.K. This September
ForbesNov 25, 2022
The Facts
On Tuesday, the National Health Service (NHS) announced that the UK will be the first country in the world to offer a jab that treats cancer in seven minutes.
The NHS will reportedly treat 3.6K patients — who suffer from lung, breast, liver, and bladder cancers, among others. The time-saving injection will be administered annually.
The Spin
Pro-establishment narrative
Atezolizumab's rollout will free up valuable time for NHS cancer teams as well as reduce cancer patients' waiting times for appointments and delays in receiving treatment. This is another example of the UK government's commitment to investing in cancer research, prevention, and treatment.
Establishment-critical narrative
Doctors and specialists across the UK are sounding the alarm as critical, life-saving treatment for thousands of patients is delayed due to staffing shortages and COVID backlogs. Before rolling out Atezolizumab, the NHS and the UK governments must develop and implement a strategy addressing its healthcare system shortcomings that cost people their lives.
